Drupal.behaviors.print = function(context) {window.print();window.close();}>

Skyline Dx, Janssen Partner on Adverse Reaction Risk Test for Multiple Myeloma Drug

July 26, 2011

Skyline Dx, Janssen Partner on Adverse Reaction Risk Test for Multiple Myeloma Drug

Skyline will collaborate with Janssen to develop a test to identify patients at increased risk of side effects from a multiple myeloma drug.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories